Your browser doesn't support javascript.
loading
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
Coombes, R C; Kilburn, L S; Snowdon, C F; Paridaens, R; Coleman, R E; Jones, S E; Jassem, J; Van de Velde, C J H; Delozier, T; Alvarez, I; Del Mastro, L; Ortmann, O; Diedrich, K; Coates, A S; Bajetta, E; Holmberg, S B; Dodwell, D; Mickiewicz, E; Andersen, J; Lønning, P E; Cocconi, G; Forbes, J; Castiglione, M; Stuart, N; Stewart, A; Fallowfield, L J; Bertelli, G; Hall, E; Bogle, R G; Carpentieri, M; Colajori, E; Subar, M; Ireland, E; Bliss, J M.
Affiliation
  • Coombes RC; Cancer Research UK Department of Cancer Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Imperial College London, Faculty of Medicine, Hammersmith Hospitals Trust, London W12 0NN, UK.
Lancet ; 369(9561): 559-70, 2007 Feb 17.
Article in En | MEDLINE | ID: mdl-17307102
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Selective Estrogen Receptor Modulators / Aromatase Inhibitors / Androstadienes Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Lancet Year: 2007 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Selective Estrogen Receptor Modulators / Aromatase Inhibitors / Androstadienes Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Lancet Year: 2007 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido